US 2012/0070428 A1Published application

Treatment of vascularized pigment epithelial detachment with anti-vegf therapy

AssigneeGenentech, Inc.

InventorsClement K. Chan, Prema Abraham

Life of this patent

Estimating the term…

Abstract

Methods for treating vascularized pigment epithelial detachment using anti-VEGF agents are disclosed.

Claims12

Dependent claims

A method of treating vascularized retinal pigment epithelial detachment (vPED) in a patient, comprising administering to the patient a high dose of an anti-VEGF therapeutic.

Dependencies are inferred from the claim text.

Facts

Application: 13/175,454Filed 1 Jul 2011
Priority: 2 Jul 2010
Published: 22 Mar 2012
Term ends: Not estimatedThe source records don’t support an estimate.

Classification11 codes

A61K 39/3955
Against materials from animals: against proteinaceous materials, e.g. enzymes, hormones, lymphokines
A61P 9/00
Drugs for disorders of the cardiovascular system
A61P 27/02
Drugs for disorders of the senses: ophthalmic agents
C07K 16/22
Against material from animals or humans: against growth factors ; against growth regulators

Family

Application61/361,295Us provisional application · filed 2 Jul 2010
US 2012/0070428 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…